Three Months Ended
March 31,
2008 2007
Cash flows from operating activities:
Net loss $(13,944) $(11,993)
Adjustments to reconcile net loss to
net
Cash used in operating activities:
Depreciation and amortization 4,210 1,435
Stock-based compensation 1,486 760
Other 16 -
Changes in operating assets and
liabilities:
Accounts receivable (3,073) (2,772)
Inventory (17,425) (9,377)
Prepaid expenses and other current assets 865 293
Accounts payable 2,978 3,063
Accrued expenses (1,493) 742
Deferred revenue 4,259 7,240
Net cash used in operating activities $(22,121) $(10,609)
NxStage Medical Inc.
Revenue by Segment
(Amounts in thousands)
Three Months Ended
March 31,
2008 2007
System One segment
Home $10,546 $5,435
Critical Care 4,321 2,939
Total System One segment 14,867 8,374
In-Center segment 16,138 -
Total
'/>"/>
SOURCE NxStage Medical, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related medicine news :1.
NxStage Medical Completes Acquisition of Medisystems2.
NxStage Medical Reports Third Quarter 2007 Results3.
NxStage Medical Establishes $50 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital4.
NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th5.
NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 20086.
NxStage Medical Reports Fourth Quarter and Full Year 2007 Results7.
Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor8.
Tsongas Visits Lawrence-based Medical Device Maker NxStage Medical, Inc.9.
NxStage Announces Supply Agreement With Kawasumi Laboratories for Blood Tubing Sets10.
MSU engineering team designs innovative medical device11.
ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference